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and connective tissue growth factor. Il-1 stimulated release of the cartilage
degeneration marker MMP-3, as well as proteins with uncharacterized
roles in cartilage pathology, such as neutrophil gelatinase-associated
lipocalin. RetA stimulated release of extracellular matrix proteins COMP,
link protein and matrilin-3 into the media, accompanied by dramatic
reduction in corresponding mRNA transcripts levels. Gelsolin, implicated
in cytoskeletal reorganization in arthritic synovial ﬁbroblasts but not pre-
viously associated with cartilage pathology, was regulated by Il-1 and
RetA.
Conclusions: This ﬁrst analysis of mouse cartilage degradation and
protein release using proteomics has identiﬁed proteins and fragments,
some of which represent novel candidate biomarkers for cartilage degra-
dation. Applying these proteomic techniques to wild-type and genetically-
modiﬁed mouse cartilage will provide insights into mechanisms of carti-
lage degeneration.
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Purpose: Some symptomatic slow-acting drugs, such as glucosamine
sulfate (GS) and chondroitin sulfate (CS), have proved efﬁcacy in relieving
the symptoms of mild and moderate osteoarthritis (OA). In vitro and
in vivo studies have demonstrated that these drugs are capable to inhibit
cartilage destruction and to promote disease suppression. However, their
mechanism of action remains poorly characterized. The aim of this study
was to evaluate the effects of these compounds on cartilage biology, alone
or in combined administration, in normal chondrocytes stimulated with
interleukin-1b (anti-inﬂammatory effect) and in osteoarthritic chondrocytes
(disease modifying effect).
Methods: Chondrocytes were obtained from 3 osteoarthritic patients
undergoing joint replacement and from 3 healthy donors. Normal chon-
drocytes were treated with GS 10mM and/or CS 200 mg/mL, and then
stimulated with Il-1b 10 ng/mL. Osteoarthritic chondrocytes were treated
with GS 10mM and CS 200 mg/mL, alone and in combination. Whole cell
proteins were isolated 24 hours after cellular stimulation and resolved
by two-dimensional electrophoresis (2-DE). The gels were stained with
SYPRORuby and digitized using a CCD camera. The image analysis was
performed using the PDQuest 7.3.1 computer software. Using PDQuest
tools, protein spots were enumerated, quantiﬁed and characterized with
respect to their molecular mass and isoelectric point by bilinear inter-
polation between landmark features on each image. Protein expression
data from each gel were normalized for the total density present in the gel
images. Differentially abundant proteins were identiﬁed by matrix-assisted
laser desorption/ionization-time of ﬂight mass spectrometry (MALDI-
TOF/TOF).
Results: We examined a mean of 500 protein spots that were present in
each gel. Both qualitative and quantitative changes in protein expression
patterns between controls and treated cells were studied. In normal
chondrocytes, 39 protein forms were modulated by GS treatment, 35 by
CS treatment and 48 by GS+CS treatment compared to the control (cells
stimulated with Il-1b). In osteoarthritic chondrocytes, 11 protein forms
were found to be statistically altered in GS treated cells, 9 in CS treated
cells and 17 in GS+CS treated cells compared to the untreated cells
(p< 0.05). Most of the identiﬁed proteins are involved in stress response
(HSP7C, HSPB1, ANXA2), cellular metabolism (AK1C2, PGK1, KPYM),
protein folding (PDIA1, PDIA3), protein targeting (GRP78) and oxidative
stress (SODM, PRDX1).
Conclusions: This study describes the differences between the pro-
tein proﬁles of normal and osteoarthritic chondrocytes treated with glu-
cosamine and/or chondroitin sulfate. We have identiﬁed novel molecular
targets that might explain the efﬁcacy of these molecules in osteoarthritis
treatment. Our results highlight the synergic effect of the combined admin-
istration and the effectiveness of the two molecules as anti-inﬂammatory
drugs (anti-IL1b effect).
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Purpose: Notch signaling induces bHLH proteins (Hes-1 and Hey-1) that
actively repress Col2a1 transcription by binding N-box domains located in
intron 1 of Col2a1. bHLH proteins also participate in passive repression
by binding activator proteins. In this current study, we tested whether
Hey-1 directly binds to Sox9 using luciferase reporter and GST-pull down
assays.
Methods: Luciferase Assays. Chondrogenic ATDC5 cells were co-
transfected using FuGENE HD (Roche). The 12x48-pGL3P-Luc luciferase
reporter plasmid that does not contain bHLH binding domains was used.
Readings were normalized by Renilla (pRL-SV40; Promega). Sox9 and
bHLH interaction was tested by over expression using pcDNA-FLAG-
Sox9 in combination with pCMV-FLAG-Hes-1 and pcDNA3-FLAG-Hey-1.
Luciferase activities were analyzed 48 hours following transfection using
the Dual-Luciferase Reporter Assay System (Promega).
GST-pull down assays. Sox9 and Hey-1 interaction was tested using
GST-Hey-1 and 35S-met-Flag-Sox9. GST-Hey-1 and 35S-HA-Hes-1 were
also utilized. The pGEX-Hey-1 expression plasmid was transduced in
BL21 cells (Stratagene), lysed and bound to Glutathione Sepharose (GE
Healthcare). A Reticulocyte system (Promega) was used to produce 35S-
met-labelled proteins (Sox9 and Hes-1). Appropriate combinations of
GST and 35S-met-labelled protein were mixed overnight at 4C. Beads
were extensively washed, placed into SDS loading buffer and loaded on
SDS-page gels (Invitrogen). Dried gels were exposed to ﬁlm for detection
of radioactive signal.
Results: Luciferase assays show that Sox9 increased reporter expres-
sion levels 70-fold relative to control (Fig. 1A). Co-transfection with
Sox9/Hes-1 and Sox9/Hey-1 led to an 81% and 64% reduction in reporter
levels, respectively (Fig. 1A). Detection of a band at 60kDa in the GST
pull down assays indicated that Sox9 and Hey-1 bind (Fig. 1B). Interaction
between Hey-1 and Hes-1 (positive control) was also observed (Fig. 1B).
Figure 1. (A) Luciferase assay showing Sox9 induction of Col2al reporter
and competitive inhibition of reporter signal by Hes-1 and Hey-1. (B) GST-
Pulldown assay demonstrating that Hey-1 and Sox9 proteins (lane 3) and
Hes-1 and Hey-1 proteins (lane 8) interact. (lane 1=20% onput 35S-met-
Sox9; lane 2=GST-Hey beads only; lane 3=GST-Hey beads+35S-met-
Sox9; lane 4=GST-null beads+35S-met-Sox9; lane 5=plain beads+35S-
met-Sox9; lane 6=20% onput 35S-met-HA-Hes; lane 7=GST-null beads
only; lane 8=GST-Hey+35S-met-HA-Hes; lane 9=GST-null beads+35S-
met-HA-Hes; lane 10=plain beads+35S-met-HA-Hes).
Conclusions: These data indicate that Hey-1 passively represses Col2a1
transcription by directly binding to Sox9. Since a reduced luciferase
signal was observed with Hes-1/Sox9 co-transfection, we suggest that
this bHLH also binds to Sox9. We propose that high bHLH levels repress
Col2a1 transcription both actively and passively. The elevated bHLH
milieu leads to passive repression by competitively binding with Sox9.
During chondrogenesis, Notch signaling and bHLH levels are reduced,
which permits a shift away from a repression environment to allow Sox9
to drive transcription.
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